Efficacy of sublingual allergen immunotherapy in asthma with allergic rhinitis

Not Applicable

Recruiting

• Conditions: Asthma with allergic rhinitis

• Registration Number: JPRN-UMIN000022390
• Lead Sponsor: Atami Hospital, International University of Health and Welfare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-20
• Study Completion: 2023-03-31
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients who have severe allergic reactions to this tablet. 2.Malignancy. 3.Strong severe ashma patients. 4.Pregnancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum periostin(after treatment at weeks 24,48, and 96)

Secondary Outcome Measures

Name	Time	Method
Pulmonary function FeNO airway wall thckness Qo